Cleared Special

K150813 - iTClamp50

K150813 is an FDA 510(k) clearance for iTClamp50, manufactured by Innovative Trauma Care, Inc.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Special 510(k) pathway after a 34-day FDA review.

K150813 · Innovative Trauma Care, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2015
Decision
34d
Days
Class 2
Risk

K150813 is an FDA 510(k) clearance for the iTClamp50. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Innovative Trauma Care, Inc. (San Antonio, US). The FDA issued a Cleared decision on April 30, 2015 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K150813

510(k) Number K150813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 2015
Decision Date April 30, 2015
Days to Decision 34 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 125d · This submission: 34d
Pathway characteristics
Modification to existing cleared device.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 192
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K150813.
TR BAND Radial Compression Device
K152525 · Terumo Medical Corporation · Nov 2015
Zephyr Vascular Compression Device
K151363 · Advanced Vascular Dynamics · Jul 2015
Bookwalter Gordon Adjustable Compression Element
K143078 · Symmetry Surgical · May 2015
CROC
K141685 · Combat Medical Systems, LLC · Jan 2015
RADAR VASCULAR COMPRESSION DEVICE
K142122 · Advanced Vascular Dynamics · Dec 2014
Vasc Band hemostat
K142359 · Lepu Medical Technology (Beijing) Co., Ltd. · Oct 2014